What does APOTHEEK ORSCAMP do?

APOTHEEK ORSCAMP is a pharmacy in Oostkamp. Public Limited, started on 19 December 1986, 1 establishment.

What is the address of APOTHEEK ORSCAMP?

The registered office of APOTHEEK ORSCAMP is located at Kortrijksestraat 48, 8020 Oostkamp.

Is APOTHEEK ORSCAMP still active?

Yes. According to the CBE (29 October 2026) APOTHEEK ORSCAMP is active, legal situation “Normale toestand”, started on 19 December 1986.

Is APOTHEEK ORSCAMP registered on Peppol?

Yes, APOTHEEK ORSCAMP is registered on the Peppol network with ID 0208:0430106908.

What is the enterprise number of APOTHEEK ORSCAMP?

The enterprise number of APOTHEEK ORSCAMP is BE0430106908.

When was APOTHEEK ORSCAMP founded?

APOTHEEK ORSCAMP was founded on 19 December 1986.

Who are the directors of APOTHEEK ORSCAMP?

According to the 2025 annual accounts, the directors of APOTHEEK ORSCAMP are: BRIGITTA VLOEBERGHS, HANS DELPUTTE.

Is APOTHEEK ORSCAMP a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 19 December 1986; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did APOTHEEK ORSCAMP make in 2025?

APOTHEEK ORSCAMP posted a profit after taxes of € 26,023 in financial year 2025.

What is the revenue of APOTHEEK ORSCAMP?

As a small company, APOTHEEK ORSCAMP is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 84,508.

How many employees does APOTHEEK ORSCAMP have?

According to the 2025 annual accounts, APOTHEEK ORSCAMP has 0.4 full-time equivalents (FTE).

Does APOTHEEK ORSCAMP have a website?

Yes, APOTHEEK ORSCAMP has a website at apotheekdelputte.be.

APOTHEEK ORSCAMP (Public Limited) - Oostkamp

Dossier APOTHEEK ORSCAMP, printed on 29 October 2026 from databakkes.be/en/0430106908/apotheek-orscamp. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

APOTHEEK ORSCAMP from Oostkamp, company number BE0430106908, closed financial year 2025 with a result of € 26,023 after tax. For that financial year APOTHEEK ORSCAMP recorded a gross margin of € 84,508 and equity of € 373,402. Compared with financial year 2024, the result moved from € 40,388 to € 26,023. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 29, 2026.

What it is worth Healthy

€ 373,402

▼ 5% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 26,023

▼ 36% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 113,646

▼ 14% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 46,627 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents

0.4

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 11,112

▲ 67% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt ≈ 5 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 107,038

▼ 34% vs 2024

€ 21,057 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.

Owed to suppliers

€ 15,453

▼ 68% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 16,360

▲ 235% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 159,219 Gross margin 2022: € 159,219 First fiscal year in the series	€ 121,697 Gross margin 2023: € 121,697 ▼ 24% vs 2022 (€ 159,219) Unfavourable step	€ 97,256 Gross margin 2024: € 97,256 ▼ 20% vs 2023 (€ 121,697) Unfavourable step	€ 84,508 Gross margin 2025: € 84,508 ▼ 13% vs 2024 (€ 97,256) Unfavourable step	▼ 13%
Profit after taxes	€ 67,495 Profit after taxes 2022: € 67,495 First fiscal year in the series	€ 49,570 Profit after taxes 2023: € 49,570 ▼ 27% vs 2022 (€ 67,495) Unfavourable step	€ 40,388 Profit after taxes 2024: € 40,388 ▼ 19% vs 2023 (€ 49,570) Unfavourable step	€ 26,023 Profit after taxes 2025: € 26,023 ▼ 36% vs 2024 (€ 40,388) Unfavourable step	▼ 36%
Equity	€ 396,378 Equity 2022: € 396,378 First fiscal year in the series	€ 402,283 Equity 2023: € 402,283 ▲ 1% vs 2022 (€ 396,378) Favourable step	€ 394,005 Equity 2024: € 394,005 ▼ 2% vs 2023 (€ 402,283) Unfavourable step	€ 373,402 Equity 2025: € 373,402 ▼ 5% vs 2024 (€ 394,005) Unfavourable step	▼ 5%
Total debts	€ 374,117 Total debts 2022: € 374,117 First fiscal year in the series	€ 375,555 Total debts 2023: € 375,555 Unchanged (€ 374,117) Unfavourable step	€ 322,918 Total debts 2024: € 322,918 ▼ 14% vs 2023 (€ 375,555) Favourable step	€ 250,161 Total debts 2025: € 250,161 ▼ 23% vs 2024 (€ 322,918) Favourable step	▼ 23%
Cash	€ 179,274 Cash 2022: € 179,274 First fiscal year in the series	€ 194,844 Cash 2023: € 194,844 ▲ 9% vs 2022 (€ 179,274) Favourable step	€ 131,724 Cash 2024: € 131,724 ▼ 32% vs 2023 (€ 194,844) Unfavourable step	€ 113,646 Cash 2025: € 113,646 ▼ 14% vs 2024 (€ 131,724) Unfavourable step	▼ 14%
Land & buildings	€ 333,881 Land & buildings 2022: € 333,881 First fiscal year in the series	€ 313,112 Land & buildings 2023: € 313,112 ▼ 6% vs 2022 (€ 333,881) Unchanged	€ 292,343 Land & buildings 2024: € 292,343 ▼ 7% vs 2023 (€ 313,112) Unchanged	€ 271,574 Land & buildings 2025: € 271,574 ▼ 7% vs 2024 (€ 292,343) Unchanged	▼ 7%
Retained profit	€ 334,378 Retained profit 2022: € 334,378 First fiscal year in the series	€ 340,283 Retained profit 2023: € 340,283 ▲ 2% vs 2022 (€ 334,378) Favourable step	€ 332,005 Retained profit 2024: € 332,005 ▼ 2% vs 2023 (€ 340,283) Unfavourable step	€ 311,402 Retained profit 2025: € 311,402 ▼ 6% vs 2024 (€ 332,005) Unfavourable step	▼ 6%
Dividend	€ 25,000 Dividend 2022: € 25,000 First fiscal year in the series	€ 43,666 Dividend 2023: € 43,666 ▲ 75% vs 2022 (€ 25,000) Unchanged	€ 48,666 Dividend 2024: € 48,666 ▲ 11% vs 2023 (€ 43,666) Unchanged	€ 46,627 Dividend 2025: € 46,627 ▼ 4% vs 2024 (€ 48,666) Unchanged	▼ 4%
Bank debt	€ 232,907 Bank debt 2022: € 232,907 First fiscal year in the series	€ 209,601 Bank debt 2023: € 209,601 ▼ 10% vs 2022 (€ 232,907) Favourable step	€ 161,944 Bank debt 2024: € 161,944 ▼ 23% vs 2023 (€ 209,601) Favourable step	€ 107,038 Bank debt 2025: € 107,038 ▼ 34% vs 2024 (€ 161,944) Favourable step	▼ 34%
Balance sheet total	€ 770,495 Balance sheet total 2022: € 770,495 First fiscal year in the series	€ 777,838 Balance sheet total 2023: € 777,838 ▲ 1% vs 2022 (€ 770,495) Unchanged	€ 716,923 Balance sheet total 2024: € 716,923 ▼ 8% vs 2023 (€ 777,838) Unchanged	€ 623,563 Balance sheet total 2025: € 623,563 ▼ 13% vs 2024 (€ 716,923) Unchanged	▼ 13%
Employees (FTE)	0.6 Employees (FTE) 2022: 0.6 First fiscal year in the series	0.6 Employees (FTE) 2023: 0.6 Unchanged (0.6) Unchanged	0.4 Employees (FTE) 2024: 0.4 ▼ 0.2 vs 2023 (0.6) Unchanged	0.4 Employees (FTE) 2025: 0.4 Unchanged (0.4) Unchanged

Key figures of APOTHEEK ORSCAMP, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK ORSCAMP?

What happened at APOTHEEK ORSCAMP in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2027 BRIGITTA VLOEBERGHS stepped down as director. NBB
2027 HANS DELPUTTE stepped down as director. NBB
May 29, 2026 New annual accounts for financial year 2025: profit of € 26,023 (▼ 36% vs 2024). Source: NBB ↗
2021 BRIGITTA VLOEBERGHS became a director. NBB
2021 HANS DELPUTTE became a director. NBB
Jan 23, 1987 New establishment in Oostkamp. KBO
Dec 19, 1986 Start of the company according to the CBE. KBO

In short

From € 67,495 profit in 2022 to € 26,023 profit in 2025.

Paid € 60,338 in corporate taxes since 2022.

Best year ever: 2022, with € 67,495 profit.

Paid out € 163,959 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Directors

According to the 2025 annual accounts

BRIGITTA VLOEBERGHS

Director

since 2021 · until 2027

HANS DELPUTTE

Managing director

since 2021 · until 2027

Establishments

Establishment units

Physical locations of this company

Registered office

Kortrijksestraat 48

8020 Oostkamp

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

Poaterke

€ 24,231 gross margin · 2025

LPS INVEST

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTP apotheekdelputte.be

Technologies

ApachePHP

Hosting & Email

Email provider

Self-hosted

Hosting

CLDIN-NL Your Hosting B.V. part of Your.Online, NL

Website info

HTTPS Nee

Languages NL

Features

Security

✗ HTTPS

✓ SPF

✗ DMARC

Network

✓ IPv6

Details

Company number

0430.106.908

VAT number

BE 0430.106.908

Registered office

Kortrijksestraat 48, 8020 Oostkamp

Names & denominations

APOTHEEK ORSCAMP

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

19 December 1986

Peppol

Active · Active since 9 Jan 2026

Contact

apotheekdelputte.be

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

Verhuur en exploitatie van eigen of geleased residentieel onroerend goed, exclusief sociale woningen

View on CBE Public ↗ Annual accounts (NBB) ↗